Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report

Abstract

Supplement Articles| December 01 2011 Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report EXPERT PANEL ON INTEGRATED GUIDELINES FOR CARDIOVASCULAR HEALTH AND RISK REDUCTION IN CHILDREN AND ADOLESCENTS EXPERT PANEL ON INTEGRATED GUIDELINES FOR CARDIOVASCULAR HEALTH AND RISK REDUCTION IN CHILDREN AND ADOLESCENTS Search for other works by this author on: This Site PubMed Google Scholar Address correspondence to Janet M. de Jesus, MS, RD, 31 Center Dr, Building 31, Room 4A17, MSC 2480, Bethesda, MD 20892. E-mail: FINANCIAL DISCLOSURE: Dr Daniels has served as a consultant for Abbott Laboratories, Merck, and Schering-Plough and has received funding/grant support for research from the National Institutes of Health (NIH); Dr Gidding has served as a consultant for Merck and Schering-Plough and has received funding/grant support for research from GlaxoSmithKline; Dr Gillman has given invited talks for Nestle Nutrition Institute and Danone and has received funding/grant support for research from Mead Johnson, Sanofi-Aventis, and the NIH; Dr Gottesman has served on the Health Advisory Board, Child Development Council of Franklin County, was a consultant to Early Head Start for Region 5B, has written for iVillage and taught classes through Garrison Associates for the State of Ohio, Bureau of Early Intervention Services and Help Me Grow program, and has received funding/grant support for research from the NIH; Dr Kwiterovich has served as a consultant or advisory board member for Merck, Schering-Plough, Pfizer, Sankyo, LipoScience, and Astra Zeneca, has served on speaker's bureaus for Merck, Schering-Plough, Pfizer, Sankyo, Kos, and Astra Zeneca, and has received funding/grant support for research from Pfizer, Merck, GlaxoSmithKline, Sankyo, and Schering-Plough; Dr McBride has served as a consultant or advisory board member for Bristol-Myers Squibb and Merck and has served on speaker's bureaus for Kos, Merck, and Pfizer but declares no relevant relationships since July 2007; Dr McCrindle has been a consultant for Abbott, Bristol-Myers Squibb, Daichii Sankyo, and Roche, owns stock in CellAegis and reports funding/grant support for research from Astra Zeneca, Sankyo, Merck, Schering-Plough, and the NIH; Dr Urbina reports funding/grant support for research from Merck, Schering-Plough, Sankyo, and the NIH; and Dr VanHorn has provided advice to Chartwells School Food Service and has received funding/grant support for research from General Mills and the NIH. Drs Benuck, Christakis, Dennison, O'Donnell, Rocchini, and Washington have indicated they have no financial relationships relevant to this article to disclose. Pediatrics (2011) 128 (Supplement_5): S213–S256. https://doi.org/10.1542/peds.2009-2107C Article history Accepted: September 08 2011 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation EXPERT PANEL ON INTEGRATED GUIDELINES FOR CARDIOVASCULAR HEALTH AND RISK REDUCTION IN CHILDREN AND ADOLESCENTS; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report. Pediatrics December 2011; 128 (Supplement_5): S213–S256. 10.1542/peds.2009-2107C Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search toolbar search search input Search input auto suggest filter your search All PublicationsAll JournalsPediatricsHospital PediatricsPediatrics In ReviewNeoReviewsAAP Grand RoundsAAP NewsAll AAP Sites Search Advanced Search Subjects: Managed Care Q&A Topics: atherosclerosis, cardiovascular diseases, cardiovascular system, diet, dyslipidemias, heart disease risk factors, hypertension, lipids, obesity, overweight Atherosclerotic cardiovascular disease (CVD) remains the leading cause of death in North Americans, but manifest disease in childhood and adolescence is rare. By contrast, risk factors and risk behaviors that accelerate the development of atherosclerosis begin in childhood, and there is increasing evidence that risk reduction delays progression toward clinical disease. In response, the former director of the National Heart, Lung, and Blood Institute (NHLBI), Dr Elizabeth Nabel, initiated development of cardiovascular health guidelines for pediatric care providers based on a formal evidence review of the science with an integrated format addressing all the major cardiovascular risk factors simultaneously. An expert panel was appointed to develop the guidelines in the fall of 2006. The goal of the expert panel was to develop comprehensive evidence-based guidelines that address the known risk factors for CVD (Table 1-1) to assist all primary pediatric care providers in both the promotion of cardiovascular... You do not currently have access to this content.

Keywords

Related Publications